Linavonkibart (SRK181) is a humanized antibody targeting TGFbeta1 that blocks the release of TGF-beta1 protein by specifically binding latent TGF-beta1.
Purity:
99.40%
CAS Number:
[2640981-30-0]
Target:
TGF-beta/Smad
* VAT and and shipping costs not included. Errors and price changes excepted